Equity Transactions (Details Narrative) - USD ($)			3 Months Ended			6 Months Ended
	Feb. 02, 2021	Jul. 02, 2020	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Jun. 30, 2021	Jul. 01, 2020	Jun. 30, 2020
Common stock issued during period for consulting services, shares						35,000
Common stock issued during period for acquisition value						$ 175,000
Common stock shares issued				83,334			83,334
Gross proceeds from sale of stocks	$ 50,000
Common stock shares authorized						100,000,000		100,000,000		100,000,000
Common stock shares par value						$ 0.001				$ 0.001
Common stock shares outstanding						16,378,006		15,262,394		15,262,394
Preferred stock shares issued						500,000		500,000		500,000
Preferred stock shares authorized						100,000,000		100,000,000		1,000,000
Preferred stock shares authorized, par value						$ 0.001		$ 0.001		$ 0.001
Issuance of common stock for acquisition of Infusionz, amount			$ 1,764,876	$ 155,125	$ 340,000
Board of Directors [Member]
Preferred stock shares issued						500,000
Preferred stock shares authorized						1,000,000
Preferred stock shares authorized, par value						$ 0.001
Convertible Preferred Stock [Member]
Preferred stock convertible into shares of common stock ratio	The preferred stock is convertible into the Company’s common stock at a ratio of 1.8 shares of preferred stock for a single share of the Company’s common stock at the holder’s option, has preferential liquidation rights and the preferred stock shall vote together
Interactive Offers, LLC [Member]
Common stock issued during period for acquisition value						$ 666,667
Common stock issued during period for acquisition						4,000,000
Infusionz [Member] | Common Stocks [Member]
Common stock issued during period for acquisition value						$ 1,764,876
Common stock issued during period for acquisition						306,945
Issuance of common stock for acquisition of Infusionz, shares							323,612
Issuance of common stock for acquisition of Infusionz, amount							$ 495,125
VitaMedica [Member]
Common stock issued during period for acquisition value						$ 482,000
Common stock issued during period for acquisition						100,000
FinderFee [Member]
Common stock issued during period for acquisition value						$ 33,740
Common stock issued during period for acquisition						7,000
Trunano Labs, Inc. Common Stock [Member] | July 1, 2020 [Member]
Common stock issued during period for acquisition value						$ 127,500
Common stock shares issued						270,270			7,261,261
Common stock shares authorized						5,770,270			10,000,000
Common stock shares par value									$ 0.001
Common stock shares outstanding									7,261,261
Minority interest						$ 1,277,778
Convertion of shares into common stocks noncontrolling shareholders		1,761,261				1,761,261
Outstanding stock conversion		1,277,778				1,277,778
Common stock, percentage of outstanding shares		10.80%				10.80%
Cash proceeds						$ 300,000